Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Zhen Guan

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Effect of expression of coxsackie and adenovirus receptor on antitumor activity of genetically modified adenovirus]Zhong-Yu Yuan, Zhong-Zhen Guan, Li Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 10, 2005
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 22, 2003
[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]Zhong-Yu Yuan, Rui-Hua Xu, You-Jian He, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|March 26, 2003
[Safety of an E1B deleted adenovirus administered intratumorally to patients with cancer]Zhong-Yu Yuan, Li Zhang, Su Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)]Li Zhang, Yang Zhang, Ning Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 3, 2007
[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study]Li-Kun Chen, Guang-Chuan Xu, Zhong-Zhen Guan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|May 15, 2004
[Effect of epidermal growth factor receptor-selective tyrosine kinase inhibitor ZD1839 on nasopharyngeal carcinoma cells]Shu-Sen Wang, Zhong-Zhen Guan, Wen-Qi Jiang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Studies on 5-FU/PEG-PBLG nano-micelles: preparation, characteristics, and drug releasing in vivo]Su Li, Wen-Qi Jiang, An-Xun Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative]Feng-Hua Wang, Yu-Hong Li, Su Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 17, 2008
[Primary safety analysis of trastuzumab after adjuvant chemotherapy in 30 Chinese Her2-positive early breast cancer patients]Ning-Ning Zhou, Xiao-Yu Teng, Dong-Geng Liu, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Effect of expression of coxsackie and adenovirus receptor on antitumor activity of genetically modified adenovirus]Zhong-Yu Yuan, Zhong-Zhen Guan, Li Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 10, 2005
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 22, 2003
[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]Zhong-Yu Yuan, Rui-Hua Xu, You-Jian He, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|March 26, 2003
[Safety of an E1B deleted adenovirus administered intratumorally to patients with cancer]Zhong-Yu Yuan, Li Zhang, Su Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)]Li Zhang, Yang Zhang, Ning Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 3, 2007
[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study]Li-Kun Chen, Guang-Chuan Xu, Zhong-Zhen Guan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|May 15, 2004
[Effect of epidermal growth factor receptor-selective tyrosine kinase inhibitor ZD1839 on nasopharyngeal carcinoma cells]Shu-Sen Wang, Zhong-Zhen Guan, Wen-Qi Jiang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Studies on 5-FU/PEG-PBLG nano-micelles: preparation, characteristics, and drug releasing in vivo]Su Li, Wen-Qi Jiang, An-Xun Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative]Feng-Hua Wang, Yu-Hong Li, Su Li, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 17, 2008
[Primary safety analysis of trastuzumab after adjuvant chemotherapy in 30 Chinese Her2-positive early breast cancer patients]Ning-Ning Zhou, Xiao-Yu Teng, Dong-Geng Liu, et al.
Pageof 11